A Case-Control Study to Estimate the Effectiveness of Maternal Pertussis Vaccination in Protecting Newborn Infants in England and Wales, 2012-2013
Author(s) -
Gavin Dabrera,
Gayatri Amirthalingam,
Nick Andrews,
Helen Campbell,
Steve Biko Menezes Hora Alves Ribeiro,
Edna Kara,
Norman K. Fry,
Mary Ramsay
Publication year - 2014
Publication title -
clinical infectious diseases
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.44
H-Index - 336
eISSN - 1537-6591
pISSN - 1058-4838
DOI - 10.1093/cid/ciu821
Subject(s) - medicine , vaccination , odds ratio , pertussis vaccine , pediatrics , pregnancy , confidence interval , whooping cough , immunization , obstetrics , immunology , antibody , biology , genetics
Infants with pertussis infection are at risk of severe clinical illness and death. Several countries, including the United Kingdom, have introduced maternal pertussis vaccination during pregnancy to protect infants from infection following national increases in pertussis notifications. The objective of this study was to estimate the effectiveness of maternal pertussis vaccination in protecting infants against laboratory-confirmed pertussis infection.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom